HPS Pharmacies wish to give notice that the NSW Chief Health Officer has issued a safety alert for Pfizer Heparin 5000 IU in 5ml ampoules as follows:
Pfizer Heparin Injection Ampoules
5000 IU in 5ml
The safety alert was raised after one patient discovered lignocaine ampoules in a newly opened box of Pfizer Heparin 5000 IU in 5ml. Both products, manufactured by Pfizer, are of similar appearance.
If HPS Pharmacies provide imprest management services to your facility, an HPS representative will inspect your stock and quarantine all affected products for correction. Your HPS Pharmacies Pharmacy Manager/Director of Pharmacy will contact your clinicians if there is an immediate impact to your facility.
Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact your pharmacist at HPS Pharmacies, or Pfizer Australia on (02) 9850 3333.
Information regarding expected dates for supply may vary subject to delays which are out of our control. HPS Pharmacies does not accept responsibility for such changes but will endeavour to keep our clients updated as information is made available from drug manufacturers or wholesalers.